Asymchem

Asymchem Pharmaceutical Group (Tianjin) Co., Ltd. is a leading CMO enterprise in China. It is mainly engaged in research and development, process optimization, and large-scale production of cGMP standard bulk drugs, key intermediates, preparation products and biological products that meet the approval of the FDA (Food and Drug Administration). The company was successfully listed on the Shenzhen Stock Exchange in November 2016 (stock code: 002821)